OrbiMed Names Two New General Partners

NEW YORK--(BUSINESS WIRE)--OrbiMed is pleased to announce the promotion of two long-standing team members to General Partner. Matthew Rizzo and Peter Thompson will join OrbiMed’s six existing General Partners at year-end as management company owners and leaders of the firm.

Matthew Rizzo joined OrbiMed in 2010 and leads OrbiMed’s royalty monetization and private credit group. Since that time, OrbiMed has established itself as one of the industry-leading providers of structured royalty/credit healthcare financing solutions, investing nearly $3 billion across 78 royalty and credit investments during the past two decades.

Dr. Peter Thompson joined OrbiMed in 2010, initially as a Venture Partner, and more recently as a Private Equity Partner. Peter has demonstrated organizational and investment leadership, including serving as a Founder or CEO of many OrbiMed portfolio companies. Peter has led numerous transformative investments for the firm, including Synthorx, Principia Biopharma, and VelosBio.

“Peter’s promotion to General Partner is a recognition of his substantial contributions to OrbiMed’s private equity team,” stated Managing Partner Carl Gordon. “We look forward to his growing leadership in the years ahead.”

“We congratulate Matt on his leadership role in OrbiMed’s growth from a niche player to one of the largest providers of private credit and royalty monetization solutions for the life sciences industry,” noted Managing Partner Carter Neild.

“As evidenced by these promotions, OrbiMed is committed to building an institutionalized and enduring organizational structure,” stated Managing Partner Sven Borho. “Our partnership will continue to grow in the years ahead.”

About OrbiMed

OrbiMed is a leading healthcare investment firm, with $18 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

www.OrbiMed.com